Daily Archives: September 23, 2020
[Preprint] Randomized trial: Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers
23 Sep, 2020 | 14:17h | UTC
Commentary on Twitter
? #Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial ?
-1st RCT on HCQ as PrEP
-1483 HCW randomized to HCQ 1x or 2x weekly or placebo
-No difference in development of confirmed or probable COVID19 https://t.co/Gn1otqKhrW pic.twitter.com/3r0HB56h9y
— Ilan Schwartz MD PhD (@GermHunterMD) September 21, 2020
Meta-analysis: Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections
23 Sep, 2020 | 14:24h | UTCCommentary: Studies explore asymptomatic COVID-19 cases, racial inequities – CIDRAP
COVID-19 in children and young people
23 Sep, 2020 | 14:26h | UTCCOVID-19 in children and young people – Science
Commentary on Twitter
Kids and #COVID19: a concise summary of what's known on susceptibility, transmission, status of a vaccine for children, the issue of schoolshttps://t.co/b4EERO1AuR
by Matthew Snape and @russellviner
Just out @ScienceMagazine pic.twitter.com/FVidH3YuZQ— Eric Topol (@EricTopol) September 21, 2020
Long-term COVID-19 containment will be shaped by strength, duration of immunity
23 Sep, 2020 | 14:51h | UTCOriginal Article: Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years – Science
Perspective: Which Sweden do you want to believe in?
23 Sep, 2020 | 14:47h | UTCWhich Sweden Do You Want to Believe In? – McGill
The first eight months of Sweden’s COVID‐19 strategy and the key actions and actors that were involved
23 Sep, 2020 | 14:48h | UTC
COVID-19 clinical trials: Learning from exceptions in the research chaos
23 Sep, 2020 | 14:50h | UTCCOVID-19 clinical trials: learning from exceptions in the research chaos – Nature
Commentary on Twitter
Our analysis on #COVID clinical trials on Nature Medicine. Only big randomised trials can answer rapidly & reliably. Megatrials need support from regulators, funders, health services, docs. Pre-existing trial networks helpful. Collaboration key to success. https://t.co/YlalAEMR9r pic.twitter.com/wElfXfXdol
— Kari Tikkinen (@KariTikkinen) September 22, 2020
Sweden spared surge of virus cases but many questions remain
23 Sep, 2020 | 14:45h | UTCSweden spared surge of virus cases but many questions remain – Associated Press
NICE Guideline: Low back pain and sciatica in over 16s
23 Sep, 2020 | 14:41h | UTC
Tracking COVID-19 with wastewater
23 Sep, 2020 | 14:43h | UTCTracking COVID-19 with wastewater – Nature Biotechnology
USPSTF draft statement: Insufficient evidence to screen for Vitamin D deficiency in asymptomatic adults
23 Sep, 2020 | 14:36h | UTC
NICE Guideline: Antimicrobial prescribing for insect bites and stings
23 Sep, 2020 | 14:40h | UTC
Catheter-associated urinary tract infections in adults: diagnosis, treatment, and prevention
23 Sep, 2020 | 14:35h | UTCCatheter-Associated Urinary Tract Infections in Adults: Diagnosis, Treatment, and Prevention – Journal of Hospital Medicine (free for a limited period)
Clinical review: Emerging immunotherapies in multiple myeloma
23 Sep, 2020 | 14:33h | UTCEmerging immunotherapies in multiple myeloma – The BMJ
Commentary on Twitter
Despite advances in treatment in the past 20yrs, multiple myeloma remains an incurable disease. This review summarizes the evidence of these various immunotherapies, their mechanism of action, and data on treatments' safety and efficacy #BMJEducation https://t.co/JWeMlJ89YR
— The BMJ (@bmj_latest) September 22, 2020